相关实验视频

Updated: Jul 25, 2025

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

An Orthotopic Model of Serous Ovarian Cancer in Immunocompetent Mice for in vivo Tumor Imaging and Monitoring of Tumor Immune Responses

Published on: November 28, 2010

血清性卵巢癌的高低

Rachel N Grisham¹, Beryl L Manning-Geist², M Herman Chui³

¹Department of Medicine, Gynecologic Medical Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

|June 27, 2023

概括

低度血清性卵巢癌 (LGSOC) 治疗正在发展. 针对性疗法和内分泌治疗对这种罕见的卵巢癌有前途,超越了传统化疗.

科学领域:

在瘤学瘤学.
分子生物学分子生物学
遗传学是一个遗传学.

背景情况:

低度血清性卵巢癌 (LGSOC) 是一种罕见的上皮性卵巢癌亚型.
从历史上看,LGSOC一直被认为是耐化疗的.
最近的进展为治疗提供了新的途径.

研究的目的:

审查LGSOC的不断发展的理解和治疗.
突出分子分析在指导LGSOC治疗中的作用.
讨论针对性和内分泌疗法对LGSOC管理的影响.

主要方法:

对LGSOC分子驱动因素和治疗策略的当前文献分析.
对LGSOC.下一代测序数据的审查.
检查针对性和内分泌疗法的临床试验结果.

主要成果:

线素激活蛋白激酶通路基因变异 (例如,KRAS,BRAF) 影响LGSOC的预后.
有针对性的疗法 (MEK 抑制剂,BRAF 抑制剂) 正在成为有效的治疗方法.
内分泌疗法,特别是与CDK 4/6抑制剂相结合,显示出对疾病稳定性的承诺.

结论:

治疗LGSOC正在转向基于分子形状的个性化方法.
向和内分泌疗法代表了LGSOC传统化疗的范式转变.
对组合疗法的进一步研究有可能改善LGSOC患者的治疗结果.

关键词:

低等级的血清液体是低等级的.这就是MAPKK的意思.这就是MEK MEK.卵巢癌是发生在卵巢的癌症.罕见的瘤罕见的瘤

更多相关视频

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Quantitation of Intra-peritoneal Ovarian Cancer Metastasis

Published on: July 18, 2016

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...